In vitro models

Keyphrases

Publications

volume 2, number 3-4, 2023

Sal Jones, Jennifer C Ashworth, Marian Meakin, Pamela Collier, Catherine Probert, Alison A Ritchie, Catherine L R Merry, Anna M Grabowska
Application of a 3D hydrogel-based model to replace use of animals for passaging patient-derived xenografts. In vitro models 2 (3-4) (2023)
Adrian Biddle
In vitro cancer models as an approach to identify targetable developmental phenotypes in cancer stem cells. In vitro models 2 (3-4) (2023)

volume 1, number 6, 2023

Felix Weiss, Nader Atlasy, Vince van Reijmersdal, Henk Stunnenberg, Cornelia Hulsbergen-Veelken, Peter Friedl
3D spheroid culture to examine adaptive therapy response in invading tumor cells. In vitro models 1 (6) (2023)
Felix Weiss, Nader Atlasy, Vince van Reijmersdal, Henk Stunnenberg, Cornelia Hulsbergen-Veelken, Peter Friedl
3D spheroid culture to examine adaptive therapy response in invading tumor cells. In vitro models 1 (6) (2023)
Felix Weiss, Nader Atlasy, Vince van Reijmersdal, Henk Stunnenberg, Cornelia Hulsbergen-Veelken, Peter Friedl
3D spheroid culture to examine adaptive therapy response in invading tumor cells. In vitro models 1 (6) (2023)
Felix Weiss, Nader Atlasy, Vince van Reijmersdal, Henk Stunnenberg, Cornelia Hulsbergen-Veelken, Peter Friedl
3D spheroid culture to examine adaptive therapy response in invading tumor cells. In vitro models 1 (6) (2023)

volume 1, number 2, 2022

Katarina Pedersen, Anne Vanhoestenberghe, Susan Heavey
Urgent action is required to increase sustainability in in vitro modelling. In vitro models 1 (2) (2022)

volume 1, number 3, 2022

Abhishek Joshi, Arun Soni, Sanjeev Acharya
In vitro models and ex vivo systems used in inflammatory bowel disease. In vitro models 1 (3) (2022)
Abhishek Bhattacharjee, Roberta M Sabino, Justin Gangwish, Vignesh K Manivasagam, Susan James, Ketul C Popat, Melissa M Reynolds, Yan Vivian Li
A novel colorimetric biosensor for detecting SARS-CoV-2 by utilizing the interaction between nucleocapsid antibody and spike proteins. In vitro models 1 (3) (2022)

volume 1, number 4-5, 2022

Lucia Iafrate, Maria Cristina Benedetti, Samantha Donsante, Alessandro Rosa, Alessandro Corsi, Richard O C Oreffo, Mara Riminucci, Giancarlo Ruocco, Chiara Scognamiglio, Gianluca Cidonio
Modelling skeletal pain harnessing tissue engineering. In vitro models 1 (4-5) (2022)
Lucia Iafrate, Maria Cristina Benedetti, Samantha Donsante, Alessandro Rosa, Alessandro Corsi, Richard O C Oreffo, Mara Riminucci, Giancarlo Ruocco, Chiara Scognamiglio, Gianluca Cidonio
Modelling skeletal pain harnessing tissue engineering. In vitro models 1 (4-5) (2022)
Diane Frances Lee, Clare L Thompson, Ronald E Baynes, Hiroko Enomoto, Geof W Smith, Mark Andrew Chambers
Development and evaluation of a bovine lung-on-chip (bLOC) to study bovine respiratory diseases. In vitro models 1 (4-5) (2022)
Diane Frances Lee, Clare L Thompson, Ronald E Baynes, Hiroko Enomoto, Geof W Smith, Mark Andrew Chambers
Development and evaluation of a bovine lung-on-chip (bLOC) to study bovine respiratory diseases. In vitro models 1 (4-5) (2022)
Sabrina Schnur, Vanessa Wahl, Julia K Metz, Jessica Gillmann, Fabian Hans, Katharina Rotermund, Ralf-Kilian Zäh, Dietmar A Brück, Marc Schneider, Marius Hittinger
Inflammatory bowel disease addressed by Caco-2 and monocyte-derived macrophages: an opportunity for an in vitro drug screening assay. In vitro models 1 (4-5) (2022)
Erick Orozco Morato, Brittany Knight, Lakshmi S Nair
Transcriptional profiling of neuronal ion channels in dorsal root ganglion-derived immortal cell line (F-11) under different culture conditions. In vitro models 1 (4-5) (2022)
Erick Orozco Morato, Brittany Knight, Lakshmi S Nair
Transcriptional profiling of neuronal ion channels in dorsal root ganglion-derived immortal cell line (F-11) under different culture conditions. In vitro models 1 (4-5) (2022)
Erick Orozco Morato, Brittany Knight, Lakshmi S Nair
Transcriptional profiling of neuronal ion channels in dorsal root ganglion-derived immortal cell line (F-11) under different culture conditions. In vitro models 1 (4-5) (2022)

volume 1, number 6, 2022

Hannah K Heywood, Laurence Gardner, Martin M Knight, David A Lee
Oscillations of the circadian clock protein, BMAL-1, align to daily cycles of mechanical stimuli: a novel means to integrate biological time within predictive in vitro model systems. In vitro models 1 (6) (2022)
James Whiteford, Samantha Arokiasamy, Clare L Thompson, Neil P Dufton
Novel application of live imaging to determine the functional cell biology of endothelial-to-mesenchymal transition (EndMT) within a liver-on-a-chip platform. In vitro models 1 (6) (2022)
James Whiteford, Samantha Arokiasamy, Clare L Thompson, Neil P Dufton
Novel application of live imaging to determine the functional cell biology of endothelial-to-mesenchymal transition (EndMT) within a liver-on-a-chip platform. In vitro models 1 (6) (2022)
Hannah K Heywood, Laurence Gardner, Martin M Knight, David A Lee
Oscillations of the circadian clock protein, BMAL-1, align to daily cycles of mechanical stimuli: a novel means to integrate biological time within predictive in vitro model systems. In vitro models 1 (6) (2022)
Hannah K Heywood, Laurence Gardner, Martin M Knight, David A Lee
Oscillations of the circadian clock protein, BMAL-1, align to daily cycles of mechanical stimuli: a novel means to integrate biological time within predictive in vitro model systems. In vitro models 1 (6) (2022)
Hannah K Heywood, Laurence Gardner, Martin M Knight, David A Lee
Oscillations of the circadian clock protein, BMAL-1, align to daily cycles of mechanical stimuli: a novel means to integrate biological time within predictive in vitro model systems. In vitro models 1 (6) (2022)

volume 1, number 1, 2021

Julia Katharina Metz, Marius Hittinger, Claus-Michael Lehr
In vitro tools for orally inhaled drug products-state of the art for their application in pharmaceutical research and industry and regulatory challenges. In vitro models 1 (1) (2021)
Julia Katharina Metz, Marius Hittinger, Claus-Michael Lehr
In vitro tools for orally inhaled drug products-state of the art for their application in pharmaceutical research and industry and regulatory challenges. In vitro models 1 (1) (2021)